Peptide and peptide-based inhibitors of SARS-CoV-2 entry.

"the structure of this complex was elucidated early in this year 2020 and the first coordinates were reported in the protein data bank under the id codes: 6vw1 [ ] 6m17 [ ] 6lzg [ ] and 6m0j [ ]."

"Declaration of Competing Interest We declare no conflicts of interest."

"We thank Elisabeth Braun and Daniel Sauter for critically reviewing the manuscript. This work was supported by the German Research Foundation (DFG) under the collaborative research center CRC 1279 “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents” (JM, ES-G and FK). FK received funding from the BMBF (“Restrict SARS-CoV-2”), JM received funding through the EU 2020 Horizon project “Fight-nCoV”. ES-G. was also supported by the DFG under the collaborative research center 1093 (CRC 1093 “Supramolecular Chemistry and Proteins”) and Germany's Excellence Strategy – EXC 2033–390677874 – RESOLV. JAM was funded by an individual research grant of the DFG. FK, JM, and JAM are funded by grants from the Ministry of Science, Research and the Arts of the State of Baden-Württemberg. JAM is indebted to the 10.13039/100008316Baden-Württemberg Stiftung for the financial support of this research project by the Elite-Program for Postdocs. DS is part of the International Graduate School in Molecular Medicine, Ulm University. We thank Elisabeth Braun and Daniel Sauter for critically reviewing the manuscript. This work was supported by the German Research Foundation (DFG) under the collaborative research center CRC 1279 “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents” (JM, ES-G and FK). FK received funding from the BMBF (“Restrict SARS-CoV-2”), JM received funding through the EU 2020 Horizon project “Fight-nCoV”. ES-G. was also supported by the DFG under the collaborative research center 1093 (CRC 1093 “Supramolecular Chemistry and Proteins”) and Germany's Excellence Strategy – EXC 2033–390677874 – RESOLV. JAM was funded by an individual research grant of the DFG. FK, JM, and JAM are funded by grants from the Ministry of Science, Research and the Arts of the State of Baden-Württemberg. JAM is indebted to the 10.13039/100008316Baden-Württemberg Stiftung for the financial support of this research project by the Elite-Program for Postdocs. DS is part of the International Graduate School in Molecular Medicine, Ulm University."